Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
A comprehensive genetic analysis of metastatic prostate cancer has, for the first time, revealed a number of major ways in which abnormal alterations of the genome propel this aggressive form of the disease.
Study shows that a simplified intervention building on the hypertension treatment algorithm used in KP’s PHASE program can significantly improve rates of blood pressure control in the city’s safety net clinics.
Study of prostate cancer in 202 men, whose cancers had spread and were resistant to standard treatment, found that about 17 percent of these cancers belong to a deadlier subtype of metastatic prostate cancer.
With a planning process underway to re-envision Parnassus Heights and a new hospital on the horizon, change to the spaces that support our learning, teaching, patient care, and research is going to be part of the UCSF experience for many years to come. A new leader is set to join UCSF in August to help manage these changes.
The already famous CRISPR system allows scientists to edit faulty genes by cutting and replacing sections of DNA, but new and improved CRISPR techniques developed at UCSF have expanded CRISPR’s scalpel into a Swiss Army knife.
Experiments using parasitic worms in the mouse gut have revealed a surprising new form of wound repair, a finding that could help scientists develop ways to enhance the body’s natural healing abilities.